Tauriga Sciences Inc (TAUG) financial statements (2020 and earlier)

Company profile

Business Address 555 MADISON AVENUE
NEW YORK, NY 10022
State of Incorp. FL
Fiscal Year End March 31
SIC 2833 - Medicinal Chemicals and Botanical Products (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
TTM
3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
3/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments0000001
Cash and cash equivalents0000 01
Short-term investments   0000
Receivables0 0    
Inventory, net of allowances, customer advances and progress billings00   0
Inventory00   0 
Prepaid expense      0
Disposal group, including discontinued operation 0     
Other undisclosed current assets011000 
Total current assets:1110001
Noncurrent Assets
Operating lease, right-of-use asset0
Property, plant and equipment0000000
Intangible assets, net (including goodwill)     (1)2
Intangible assets, net (excluding goodwill)     (1)2
Deferred costs      0
Other undisclosed noncurrent assets     10
Total noncurrent assets:0000002
TOTAL ASSETS:1110003
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities0001111
Accounts payable0000000
Accrued liabilities0  1000
Interest and dividends payable000000 
Debt1000000
Deferred compensation liability   000 
Derivative instruments and hedges, liabilities   1102
Due to related parties    0  
Disposal group, including discontinued operation 0     
Customer refund liability00     
Other undisclosed current liabilities00  001
Total current liabilities:1002223
Noncurrent Liabilities
Long-term debt and lease obligation0      
Operating lease, liability0
Liabilities, other than long-term debt   0   
Other liabilities   0   
Other undisclosed noncurrent liabilities  0    
Total noncurrent liabilities:0 00   
Total liabilities:1003223
Stockholders' equity
Stockholders' equity attributable to parent, including:(0)10(3)(2)(1)0
Common stock0000000
Additional paid in capital57565552504842
Accumulated other comprehensive income (loss)  0(0)(0)(0)(0)
Accumulated deficit(58)(55)(54)(54)(52)(49) 
Other undisclosed stockholders' equity attributable to parent      (42)
Stockholders' equity attributable to noncontrolling interest  (0)    
Total stockholders' equity:(0)10(3)(2)(1)0
TOTAL LIABILITIES AND EQUITY:1110003

Income statement (P&L) ($ in millions)

12/31/2019
TTM
3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
3/31/2014
Revenues000  0 
Revenue, net   0 
Other income 0   
Cost of revenue(0)(0)(0) (0)(0)(1)
Cost of goods and services sold  (0)  (0)(1)
Financial services costs  (0)  
Gross profit:000 (0)0(1)
Operating expenses(2)(1)(2)(2)(2)(4)(8)
Other undisclosed operating income0   0 1
Operating loss:(2)(1)(2)(2)(2)(4)(8)
Nonoperating income (expense)(1)(0)2(1)(0)(1)(2)
Investment income, nonoperating   (0)(0) (1)
Debt instrument, convertible, beneficial conversion feature      1
Interest and debt expense(1)(0)(0)(0)(0)(0)(0)
Loss from continuing operations before equity method investments, income taxes:(3)(1)(0)(2)(3)(5)(10)
Other undisclosed income from continuing operations before income taxes10     
Loss from continuing operations before income taxes:(3)(1)(0)(2)(3)(5)(10)
Other undisclosed income from continuing operations   00  
Loss from continuing operations:(3)(1)(0)(2)(2)(5)(10)
Loss from discontinued operations (0)  (0)  
Other undisclosed loss before gain (loss) on sale of properties(0)      
Loss before gain (loss) on sale of properties:(3)(1)(0)(2)(3)(5)(10)
Other undisclosed net income (loss)(0) 0    
Net loss:(3)(1)(0)(2)(3)(5)(10)
Net loss attributable to noncontrolling interest  (0)    
Other undisclosed net income attributable to parent  0  00
Net loss attributable to parent:(3)(1)(0)(2)(3)(5)(10)
Preferred stock dividends and other adjustments  (0)    
Net loss available to common stockholders, diluted:(3)(1)(0)(2)(3)(5)(10)

Comprehensive Income ($ in millions)

12/31/2019
TTM
3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
3/31/2014
Net loss:(3)(1)(0)(2)(3)(5)(10)
Other comprehensive income (loss)  0(0)(0)(0) 
Comprehensive income (loss):(3)(1)0(2)(3)(5)(10)
Comprehensive loss, net of tax, attributable to noncontrolling interest  (0)    
Other undisclosed comprehensive income (loss), net of tax, attributable to parent  (0)  010
Comprehensive loss, net of tax, attributable to parent:(3)(1)(0)(2)(3)(5)(0)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: